3-Dimensional Pharmaceuticals

Sector:
Healthcare

Location:
New Brunswick, NJ

Year Funded:
1997

Status:
IPO/Acquired by
Johnson & Johnson


Summary:
3-Dimensional Pharmaceuticals, Inc. (3DP) was a drug discovery company integrating advanced technologies in structure-based drug design, combinatorial chemistry, and chemi-informatics.  3DP developed an efficient and cost-effective system capable of generating new drug leads through computer-controlled robotic synthesis and analysis of chemical libraries – a patented technology known as Directed Diversity. 3DP focused its technology on the discovery and optimization of small molecule, orally acting pharmaceuticals for the treatment of cardiovascular disease and cancer.